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he process of vascular smooth muscle cell (vSMC)
differentiation is critical to embryonic angiogenesis.
However, despite its importance, the vSMC differen-
tiation program remains largely undeﬁned. Murine gene
disruption studies have identiﬁed several gene products
that are necessary for vSMC differentiation, but these
methodologies cannot establish whether or not a factor is
sufﬁcient to initiate the differentiation program. A gain-of-
function system consisting of normal vSMC progenitor
cells would serve as a useful complement to whole ani-
T
 
mal loss-of-function studies. We use such a system here,
namely freshly isolated rat neural crest stem cells (NCSCs),
to show that activation of the calcineurin signaling pathway
is sufﬁcient to drive these cells toward a smooth muscle
fate. In addition, we present data suggesting that transforming
growth factor (TGF)-
 
 
 
1, which also causes NCSCs to differ-
entiate into smooth muscle, activates calcineurin signaling
in NCSCs, leading to a model in which activation of cal-
cineurin signaling is the mechanism by which TGF-
 
 
 
1
causes SMC differentiation in these cells.
 
Introduction
 
Differentiation of vascular smooth muscle cells (vSMCs)
is critical to arteriogenesis in the embryo. The first step in
arteriogenesis is vasculogenesis, during which endothelial
cells proliferate and form thin-walled tubules. Smooth
muscle progenitor cells are then recruited to ensheath these
endothelial tubules and are induced to differentiate into
smooth muscle. The endothelial tubules are unstable and
prone to regression until they are ensheathed by differenti-
ated smooth muscle, so differentiation of smooth muscle is
necessary for the development of stable, mature arteries
(Carmeliet, 2000).
A comprehensive understanding of the mechanisms of
smooth muscle differentiation has proven to be elusive,
although a role in smooth muscle cell (SMC) differentiation
has been proposed for several factors. For example, a variety
of experimental results indicate that transforming growth
factor (TGF)-
 
 
 
1 is involved in smooth muscle differentiation
(Folkman and D’Amore, 1996; Perrella et al., 1998). Dis-
ruption of the endoglin gene, which encodes an endothelial
cell surface protein that regulates TGF signaling, inhibits
vascular smooth muscle differentiation (Li et al., 1999).
Also, mice deficient for the activin-like kinase 1 TGF receptor
also exhibit poor vSMC differentiation (Oh et al., 2000). In
addition, diverse cell types differentiate into smooth muscle
when treated with TGF-
 
 
 
1. These include bovine endothelial
cells, the 10T1/2 line of murine embryonal fibroblasts,
murine embryonic stem cells, and rat neural crest stem cells
(NCSCs; Arciniegas et al., 1992; Shah et al., 1996; Drab et
al., 1997; Hirschi et al., 1998). This finding strongly suggests
that one of the normal, physiological effects of TGF-
 
 
 
1 is to
induce SMC differentiation.
Several factors other than TGF-
 
 
 
1 are also thought to
regulate smooth muscle differentiation. These factors include
GATA-6 (Morrisey et al., 1996; Mano et al., 1999), CRP1
and CRP2 (Chang et al., 2003), dHAND (Yamagishi et al.,
2000), and myocardin, which seems to act in concert with
serum response factor (Wang et al., 2001; Du et al., 2003).
However, the interplay between these factors in the differenti-
ation process, and their relative importance to differentiation,
is poorly understood. Most of the evidence that these factors
are important is derived from loss-of-function analyses,
chiefly murine gene disruption studies. These experiments
provide valuable information but cannot answer certain
important questions, like whether a given gene acts in a cell-
autonomous manner or whether it acts proximally enough
in the differentiation program to be sufficient to initiate
smooth muscle differentiation in progenitor cells.
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Purified normal SMC progenitor cells capable of differen-
tiating into smooth muscle in vitro would provide a system
sensitive to gain-of-function effects and would be extremely
useful for dissecting the pathways important for smooth
muscle differentiation. Such a progenitor cell type—the
10T1/2 cell line—was critically important in the initial
identification of MyoD as a master regulator of skeletal mus-
cle differentiation (Olson, 1990). There are a few reports of
cells that have the capacity to become smooth muscle in
vitro in response to particular stimuli, but these cells either
do not acquire a fully differentiated phenotype or only a
small fraction of cells actually differentiate (Arciniegas et al.,
1992; Drab et al., 1997; Hirschi et al., 1998). In addition,
these various cell types have all been subjected to long-term
cell culture, increasing the risk of artifactual results.
NCSCs can be purified from rat embryos and have the ca-
pacity to differentiate into smooth muscle (Shah et al.,
1996; Morrison et al., 1999). This is an excellent system
with which to study SMC differentiation—neural crest cells
are normal progenitors of vascular smooth muscle, and if
stem cells are freshly isolated for each experiment so that
time in culture is limited to relatively brief periods, artifac-
tual results due to culture should be minimized. Thus, this
system is likely to be much more physiologically relevant
than other in vitro SMC differentiation systems.
The work described here examines the effect of calcineurin
on NCSCs. Calcineurin is a calcium/calmodulin-activated
protein phosphatase, the activation of which results in de-
phosphorylation of a set of substrates, the best-characterized
of which are four NFAT transcription factors, NFATc1–c4
(Rao et al., 1997; Crabtree and Olson, 2002). Phosphory-
lated, inactive NFATs are localized to the cytoplasm. De-
phosphorylation of NFATs results in exposure of a nuclear
localization signal and translocation to the nucleus of the cell
(Shibasaki et al., 1996; Rao et al., 1997; Crabtree and Olson,
2002). There the NFATs bind to gene regulatory sequences
and, through cooperative interactions with other transcrip-
tion factors, influence gene activity. Nuclear NFATs are re-
phosphorylated by several kinases, including glycogen syn-
thase kinase (GSK)-3
 
 
 
, resulting in export from the nucleus.
Therefore, GSK-3
 
 
 
 is an antagonist of calcineurin signaling
(Antos et al., 2002; Crabtree and Olson, 2002; Fig. 1, a dia-
gram of the calcineurin signaling pathway).
Here, we describe experiments showing that calcineurin di-
rects NCSCs to a smooth muscle fate, as does the calcineurin-
activated transcription factor NFATc1. Two negative regulators
of calcineurin signaling, GSK-3
 
 
 
 and the calcineurin inhibi-
tor MCIP-1, both decrease smooth muscle differentiation.
This work provides strong evidence that calcineurin promotes
smooth muscle differentiation in cells of the neural crest lineage.
In addition, we present data suggesting that TGF-
 
 
 
1, which also
causes NCSCs to differentiate into smooth muscle, appears to
do so, at least in part, by activating calcineurin signaling.
 
Results
 
A calcineurin target gene is up-regulated in NCSCs that 
are differentiating in response to TGF-
 
 
 
1
 
Rat NCSCs differentiate into smooth muscle in response to
TGF- 
 
 
 
1 (Shah et al., 1996). In an attempt to identify fac-
tors that act downstream of TGF-
 
 
 
1 in this process, we con-
structed a subtracted cDNA library derived from sequences
that are up-regulated as NCSCs differentiate into smooth
muscle (Moon et al., 2002). One of the up-regulated
cDNAs proved to encode MCIP-1, a calcineurin inhibitor
(Rothermel et al., 2000; Moon et al., 2002). A virtual
Figure 1. An outline of the calcineurin signaling pathway. Calci-
neurin, a serine/threonine protein phosphatase, is activated by calcium 
and calmodulin after intracellular calcium levels are elevated for a 
sustained period of time. Activated calcineurin dephosphorylates 
several substrates, including the NFAT transcription factors, which 
then translocate from the cytoplasm to the nucleus and activate a 
tissue-specific set of genes. In muscle, this set of genes includes 
MCIP-1, the protein product of which inhibits calcineurin, resulting in 
a negative feedback loop. Nuclear GSK-3  rephosphorylates nuclear 
NFATs, so that they are inactivated and exported from the nucleus.
Figure 2. Virtual Northern blot demonstrates up-regulation of 
MCIP-1 expression in differentiating NCSC-derived SMCs as
compared with undifferentiated NCSCs. First-strand cDNA from 
NCSC and SMC was amplified by limited PCR, run on an agarose 
gel, blotted, and hybridized to an MCIP-1–specific probe. The filter 
was stripped and hybridized to a G3PDH probe, so that G3PDH 
serves as an internal control. 
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Northern blot confirmed up-regulation of MCIP-1 in neu-
ral crest-derived differentiating smooth muscle as compared
with pluripotent NCSCs (Fig. 2).
Calcineurin activity is chiefly regulated at the posttransla-
tional level (Rao et al., 1997). MCIP-1 gene expression is in-
duced by activated calcineurin (Yang et al., 2000), and so
MCIP-1 imposes negative feedback on calcineurin at high
levels of calcineurin activity (Fig. 1). Therefore, we reasoned
that the increased MCIP-1 mRNA levels in differentiating
SMCs might be a surrogate marker for high levels of cal-
cineurin activity in those cells. There is considerable evi-
dence that calcineurin has effects on cardiac muscle hyper-
trophy, on skeletal muscle fiber type, and on promoting
skeletal muscle differentiation (Friday et al., 2000; Rommel
et al., 2001; Crabtree and Olson, 2002), so the possibility
that calcineurin signaling was activated in differentiating
smooth muscle was of great interest.
 
Activation of the calcineurin signaling pathway 
increases the SMC fraction of an NCSC population, 
and inhibition of the calcineurin signaling pathway 
decreases the SMC fraction of an NCSC population
 
To evaluate the effect of calcineurin on the differentiation of
NCSCs into SMCs, we developed a highly quantitative flow
cytometric technique for quickly assessing the fraction of
SMCs in a NCSC population. NCSCs were transduced
with the pMIG retroviral vector (Van Parijs et al., 1999),
which expresses GFP, and were exposed to 20 pM TGF-
 
 
 
1
for 4 d to induce SMC differentiation. These cells were fixed
and stained with an antibody directed against smooth mus-
cle 
 
 
 
-actin (SMA), a marker for smooth muscle differentia-
tion. An increase in SMC differentiation and a decrease in
total cell number was observed for NCSCs treated with
TGF-
 
 
 
1, as described previously (Shah et al., 1996; Moon
et al., 2002). The fraction of cells that differentiated into
NCSCs as measured by high levels of SMA expression was
approximately three times that of controls (Fig. 3 A).
We used pMIG to express a constitutively active truncated
form of calcineurin in NCSCs. pMIG produces a bicistronic
transcript consisting of the inserted sequence as well as se-
quences encoding GFP, so that transduced cells can be iden-
tified by virtue of GFP expression. 6 d after transduction,
the cells were fixed and stained with antibody against SMA.
We analyzed the cell population by flow cytometry and
found that the fraction of SMCs was more than twice as
high in cells transduced with the calcineurin construct as
compared with cells transduced with vector alone (Fig. 3 B).
In addition, we noted that increased GFP correlates with in-
creased SMA expression in the calcineurin-expressing cells.
GFP and calcineurin are encoded on the same transcript,
and increases in GFP expression should correlate with in-
creased levels of calcineurin expression, as has been demon-
strated for other bicistronic transcripts (Collier et al., 1998;
Mizuguchi et al., 2000). Therefore, these experimental re-
sults suggest that calcineurin promotes smooth muscle dif-
ferentiation in a dose-dependent manner (Fig. 3 C).
To determine whether or not inhibitors of calcineurin sig-
naling would suppress smooth muscle differentiation, we ex-
ploited the fact that NCSCs spontaneously differentiate into
smooth muscle at a low frequency. We found that there was
a small but consistent inhibition of spontaneous SMC dif-
ferentiation by MCIP-1 (Fig. 3 B). We also examined the ef-
fect of expression of the protein kinase GSK-3
 
 
 
 on sponta-
neous SMC differentiation. GSK-3
 
 
 
 has diverse targets,
including nuclear NFATs, which it phosphorylates and in-
activates. Thus, GSK-3
 
 
 
 serves to oppose calcineurin’s
effects (Antos et al., 2002; Crabtree and Olson, 2002). Ex-
pression of constitutively active GSK-3
 
 
 
 in NCSCs con-
sistently resulted in a lower rate of spontaneous smooth
muscle differentiation (Fig. 3 B), which is consistent with
the notion that inhibition of the calcineurin pathway in-
hibits SMC differentiation. Attempts to use the pharma-
cological calcineurin inhibitor cyclosporine were unsuc-
cessful because of marked toxicity to NCSCs, even at low
concentrations.
 
Calcineurin acts in an instructive manner to initiate 
smooth muscle differentiation
 
The flow cytometry data suggest that calcineurin-expressing
cells are more likely to be SMCs than control cells, but it
does not tell us anything about the mechanism of that effect.
Specifically, flow cytometry does not allow us to discrimi-
nate between a selective effect, by which calcineurin is either
detrimental to the growth of non-SMC types or promotes
proliferation of SMCs, and an instructive effect, by which
calcineurin directs progenitor cells to the SMC differentia-
tion pathway. To discriminate between these possibilities,
we analyzed the calcineurin effect using clonal analysis.
Freshly isolated NCSCs were transduced with retroviral
constructs, and after 24 h the transduced cells were replated
at clonal density. Examination 4 h later confirmed that the
replated cells were almost exclusively single (91% in three
experiments, SD of 7%). 7 d later, the resulting cultures
were stained for SMA and each colony was characterized
with respect to its SMC content. Each of these colonies has
arisen from a single cell, and will therefore consist of cells
that are identical in terms of retroviral transduction—all the
cells in a colony are either untransduced or transduced, and
if transduced, all cells have the same number and chromo-
somal position of retroviral insertions. The resulting relative
homogeneity of phenotype facilitates characterization of
each colony and also allows a more rigorous analysis of cell
fate decisions. Using clonal analysis, the effect of calcineurin
was even more striking than in the flow cytometry experi-
ments (Fig. 4). Clonal analysis of calcineurin-expressing col-
onies showed a more than eightfold increase in colonies
composed entirely of smooth muscle as compared with
controls (Fig. 4 B, M). In addition, expression of calcineu-
rin resulted in a more than threefold decrease in the num-
ber of colonies that contained no SMCs (Fig. 4 B, U and
GU). The ratio of colony number on calcineurin-transduced
plates as compared with vector-transduced plates was 1.17,
with a SD of 0.04, so there was no evidence for a selective ef-
fect that was detrimental to non-SMCs (Fig. 4 B). SMC col-
onies on calcineurin plates were similar in size to SMC colo-
nies on control plates (unpublished data), so there was no
evidence for a selective effect that acts by promoting SMC
growth. Our interpretation of this result is that calcineurin
acts primarily by instructive means and directs NCSCs to-
ward a smooth muscle fate. 
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To characterize the degree of differentiation that cal-
cineurin is capable of inducing, we stained clonal cal-
cineurin-expressing NCSC colonies with antibodies against
smooth muscle myosin heavy chain and against calponin,
two proteins that are specific for SMCs. Cells in these colo-
nies express both of these proteins, demonstrating that cal-
cineurin induces a well-differentiated SMC phenotype (Fig.
4 C). We did not detect a qualitative difference between
SMCs that arose spontaneously in control cultures and cal-
cineurin-expressing SMCs; both were reactive with these
two SMC-specific antibodies. We conclude from this exper-
iment that calcineurin causes NCSCs to differentiate into
cells that are smooth muscle as judged by their morphology
and by the expression of multiple smooth muscle-specific
proteins.
One intriguing aspect of the flow cytometric profile of cal-
cineurin-expressing cells is that a larger fraction of cells are
untransduced as compared with flow profiles of MCIP-1
Figure 3. Calcineurin activation, like TGF- 1 treatment, increases the proportion of smooth muscle in the neural crest cell population. 
(A) TGF-mediated smooth muscle differentiation as measured by flow cytometry. Approximately 18,000 NCSCs per well isolated from sciatic 
nerve were transduced with the pMIG retroviral vector, and 2 d later 20 pM TGF- 1 was added to half of the wells. After four additional days, 
the cells were fixed and stained with a primary antibody directed against SMA and a PE-conjugated secondary antibody, and PE and GFP 
fluorescence were determined by flow cytometry. The horizontal and vertical lines on each plot denote the upper boundary of GFP-negative 
and SMA-negative NCSCs, respectively. Cells to the right of the vertical line are GFP-positive and thus successfully transduced, and cells 
above the horizontal line are SMA-positive and thus are SMCs. The percentage of cells in each quadrant is indicated. Increased SMC content 
is evident in wells treated with TGF. (B) Calcineurin expression increases the percentage of SMCs in NCSC cultures, and inhibitors of calcineurin 
activity decrease the percentage of SMCs in NCSC cultures. NCSCs were transduced the day after isolation, and then grown for 6 d. At that 
point, they were fixed and stained with a primary antibody directed against SMA and a PE-conjugated secondary antibody, and PE and GFP 
fluorescence were determined by flow cytometry. The horizontal and vertical lines on each plot denote the upper boundary of GFP-negative 
and SMA-negative NCSCs, respectively. Cells to the right of the vertical line are GFP-positive and thus successfully transduced, and cells 
above the horizontal line are SMA-positive and thus are SMCs. The percentage of transduced cells that has differentiated into smooth muscle 
is indicated in the top right of each plot. Note that the NCSCs in the calcineurin plot that express the highest GFP levels, and therefore 
presumably the highest calcineurin levels, are almost uniformly smooth muscle. Calcineurin/vector ratio of percentage of SMCs from three 
independent experiments was 2.4, with a SD of 0.06; for MCIP-1, the mean ratio was 0.6, with a SD of 0.26; and for GSK-3 , the ratio was 
0.5, with a SD of 0.15. (C) Increased expression of GFP correlates with increased SMC differentiation. Three independent flow cytometric 
analyses of calcineurin-transduced cells were evaluated for a correlation between actin expression (i.e., SMC identity) and GFP expression. 
Because GFP and calcineurin are on a bicistronic message, we expect calcineurin expression to increase in tandem with GFP expression. The 
level of actin expression at each level of intensity of GFP fluorescence is expressed as fold above a pMIG retroviral vector control   SD. 
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and GSK-3
 
 
 
 (Fig. 3 B). The results of other work with the
calcineurin-expressing retrovirus led us to doubt that this
was simply due to low rates of transduction. Rather, we sus-
pected that this was a result of a slowed mitotic rate in cal-
cineurin-expressing stem cells that have begun to differenti-
ate, so that the proportion of untransduced, undifferentiated
cells in the population increased disproportionately over the
several days that the cells were cultured. Clonal analysis con-
firmed this finding; the proportion of GFP-positive colonies
on calcineurin plates was equal to that of control plates,
demonstrating that transduction rates were equal, and
smooth muscle colonies contained many fewer cells than un-
differentiated colonies (Fig. 4 A and not depicted), presum-
ably because differentiated SMCs divide more slowly than
undifferentiated cells. These data supported our idea that
the large number of untransduced cells in flow cytometric
studies was due to relative overgrowth of untransduced cells
rather than to poor transduction rates.
 
The calcineurin-activated transcription factor NFATc1 
also causes smooth muscle differentiation
 
The predominant and best studied mechanism by which cal-
cineurin exerts its effects is by dephosphorylating and acti-
vating the four calcineurin-regulated NFAT transcription
factors. We chose to investigate whether or not calcineu-
rin mediates SMC differentiation via an NFAT-dependent
mechanism. We performed RT-PCR experiments to deter-
mine which NFAT transcripts are expressed in NCSCs, and
found that NFATc1 and NFATc3 are expressed in these
cells (unpublished data). Therefore, we constructed a retro-
viral plasmid with a FLAG-tagged NFATc1 and transduced
NCSCs with NFATc1 virus. Fig. 5 shows a photomicro-
graph of NCSCs expressing NFATc1, and shows that
NFATc1 promotes SMC differentiation of NCSCs. In this
case, the virus does not coexpress GFP, so although it is not
possible to identify transduced cells by virtue of GFP expres-
sion, as was done for the experiments shown in Fig. 3, an
NFATc1-dependent differentiation effect is clearly evident.
This case provides strong evidence that calcineurin causes
SMC differentiation in an NFAT-mediated manner.
 
TGF-
 
 
 
1 activates transcription of the NFATc1 gene
 
The fact that TGF-
 
 
 
1 activates the expression of MCIP-1,
a calcineurin target gene, and the fact that expression of ei-
ther calcineurin or NFATc1 phenocopies the TGF-
 
 
 
1 effect
(i.e., causes smooth muscle differentiation), suggests that
TGF-
 
 
 
1 may cause SMC differentiation by activating cal-
cineurin signaling. This is a compelling model because it al-
lows TGF-
 
 
 
1 and calcineurin, two factors known to play a
role in SMC differentiation, to be placed in an epistatic rela-
tionship in the same differentiation pathway. To further test
this model, we quantitated the expression level of another
Figure 4. Colonies of calcineurin-
transduced NCSCs demonstrate a marked 
increase in SMC differentiation and 
assume a highly differentiated phenotype. 
NCSCs were transduced 24 h after 
isolation and replated at clonal density on 
the following day. They were allowed to 
grow for 10 d, and then stained with 
DAPI and the indicated antibodies. (A) 
Calcineurin- and pMIG-transduced 
colonies stained with anti-SMA antibody 
are shown. They were photographed 
sequentially, in the order that they were 
encountered on the plate. (B) Colony 
characterization of calcineurin- and 
pMIG-transduced colonies. Colonies 
were stained with cell type–specific 
antibodies and characterized with respect 
to their content of undifferentiated (U), 
smooth muscle (M), or glial (G) content. 
Cn, calcineurin; Vec, pMIG. Means of 
three independent experiments plus SD 
are shown. (C) Calcineurin- or pMIG-
transduced SMCs express the highly 
specific SMC markers calponin and 
smooth muscle myosin heavy chain, 
indicating a highly differentiated pheno-
type. Note that although the degree of 
magnification may appear to be higher in 
the photographs of calcineurin-transduced 
cells, magnification of parallel photomi-
crographs in A and C is in fact the same. 
The nuclei of SMCs are larger than those 
of undifferentiated NCSCs, giving the 
incorrect impression of different degrees 
of magnification. 
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calcineurin/NFAT target gene, NFATc1 itself (Zhou et al.,
2002), after TGF-
 
 
 
1 treatment. Using quantitative real-
time PCR, we found that TGF-
 
 
 
1 treatment results in a
4.5-fold increase in NFATc1 transcript levels in NCSCs
(Fig. 6). This is further evidence that the calcineurin path-
way may be activated in TGF-
 
 
 
1–treated NCSCs.
 
Discussion
 
Using freshly isolated cells of the neural crest lineage as a
smooth muscle differentiation system responsive to gain-of-
function effects, we have shown that expression of cal-
cineurin or of the calcineurin-activated transcription factor
NFATc1 causes NCSCs to differentiate into smooth muscle
and that expression of MCIP-1 or GSK-3
 
 
 
, each of which
antagonizes calcineurin signaling, inhibits SMC differentia-
tion in these cells. Clonal analysis indicates that calcineurin
exerts its effect on NCSCs by a primarily instructive mecha-
nism rather than a selective mechanism. We found in the
clonal analysis experiments that it was necessary to wait 24 h
to replate transduced NCSCs because of markedly deleteri-
ous effects on cell viability and transduction rate when the
cells were replated sooner after transduction. This period of
time may allow some selection to take place, but there are
several reasons why we think that a significant selective effect
is unlikely. First, expression of the retroviral constructs is
minimal at 24 h after transduction, and overt differentiation
in response to factors expressed from transduced retroviral
constructs is not evident until 5–6 d after transduction (un-
published data). Therefore, it seems unlikely that a signifi-
cant selective effect could be exerted so early after transduc-
tion. In addition, comparison of experimental plates with
controls shows no evidence of a selective effect. Therefore,
we conclude that the effect of calcineurin on NCSCs is pri-
marily, and perhaps exclusively, instructive.
The fact that calcineurin is sufficient to cause SMC differ-
entiation shows that it is capable of initiating the smooth
muscle differentiation program. This is a conclusion that
could not have been made from whole animal loss-of-func-
tion experiments alone and demonstrates the value of a
physiologically relevant in vitro differentiation system.
The observation that calcineurin plays a role in smooth
muscle differentiation is not entirely surprising because the
importance of calcineurin signaling to cardiac and skeletal
muscle has already been established. Several groups have
shown that calcineurin is capable of causing cardiac hypertro-
phy, skeletal muscle fiber type switching, and skeletal muscle
differentiation (Chin et al., 1998; Friday et al., 2000; Kegley
et al., 2001; Crabtree and Olson, 2002). In addition, the
phenotypes of mice deficient for calcineurin pathway func-
tion are consistent with a role for calcineurin signaling in
SMC differentiation (Graef et al., 2001). Mice with a dis-
rupted calcineurin regulatory subunit (CnB) gene and mice
with two disrupted NFAT genes (NFATc3 and NFATc4)
have noticeable abnormalities in vSMC differentiation. In
these mice, aortic SMCs are in many cases not tightly associ-
ated with the vessel wall. In CnB knockout mice, immunore-
activity of vSMCs with smooth muscle-specific antibodies is
Figure 5. Expression of NFATc1 in NCSCs 
causes smooth muscle differentiation. (top) 
Photomicrographs of NCSCs transduced with 
MSCV vector-derived or FLAG-NFATc1–
expressing retrovirus and stained with FLAG 
antibody. (bottom) Representative example of 
flow cytometry of NCSCs transduced with MSCV 
virus (solid black peak) or NFATc1 virus (open 
peak with gray outline). Cells were fixed and 
stained for SMA expression 6 d after transduction. 
NFATc1/vector ratio of percentage of SMCs 
from three independent experiments was 2.0, 
with a SD of 0.1. 
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dramatically decreased. The authors speculate that there is no
intrinsic, cell-autonomous defect in SMC differentiation be-
cause somitic vessel SMCs look normal, but this finding
could also be explained by differing sensitivities of SMCs
from different lineages to defects in calcineurin signaling.
Vertebrate vascular smooth muscle is derived from multiple
cell types. SMCs in the proximal aorta, aortic arch, and pul-
monary trunk are derived from neural crest, whereas smooth
muscle in the descending aorta is derived from mesoderm
and probably also from transdifferentiated endothelium (Git-
tenberger-de Groot et al., 1999; Jiang et al., 2000). Smooth
muscle in the coronary arteries is derived from epicardium
(Gittenberger-de Groot et al., 1999). SMCs from different
progenitor cell types have different properties, and thus vas-
cular smooth muscle in one part of the animal is different
from vascular smooth muscle in another part (Topouzis and
Majesky, 1996). Our experiments, which show that cal-
cineurin initiates SMC differentiation in purified NCSCs,
support a model of smooth muscle differentiation wherein
the calcineurin requirement is cell-autonomous in nature. A
tenable alternative interpretation of the whole animal loss-of-
function experiments is that the calcineurin requirement is
cell-autonomous but that different progenitor cell types have
differing sensitivities to loss of calcineurin signaling.
Loss-of-function mutations in the gene encoding the
MEF2C transcription factor also result in poor vSMC dif-
ferentiation (Lin et al., 1998). The fact that MEF family
members are activated by calcineurin in cardiac and skeletal
muscle (Olson and Williams, 2000; Zhang et al., 2002) and
are known to interact with NFAT transcription factors at
target promoters constitutes further evidence of a role for
calcineurin in smooth muscle differentiation. It will be im-
portant to examine potential relationships between cal-
cineurin and MEF2C in smooth muscle differentiation.
Similarly, potential relationships between calcineurin and
other factors likely to be involved in smooth muscle differ-
entiation, like TGF-
 
 
 
1, GATA-6, and SRF (Folkman and
D’Amore, 1996; Parmacek, 2001), will be of great interest.
The mechanisms of NFAT-mediated calcineurin signaling
were elucidated primarily in immune cells (Rao et al., 1997;
Crabtree and Olson, 2002). Interestingly, the actions of cal-
cineurin in muscle and in T cells are mediated in strikingly
similar ways (Crabtree and Olson, 2002). For example, cal-
cineurin signaling in lymphocytes seems to require a cooper-
ative interaction between NFATs and other transcription
factors, like members of the MEF family and AP-1 (Liu et
al., 1997; Rao et al., 1997). Calcineurin-mediated skeletal
muscle fiber type switching also seems to act via an associa-
tion between NFAT and MEF transcription factors (Calvo
et al., 1999; Wu et al., 2000). This finding suggests that the
mechanisms of NFAT-mediated calcineurin signaling are
likely to be conserved, in general outline and perhaps in sig-
nificant detail, in NCSCs.
Activation of the calcineurin signaling pathway in re-
sponse to TGF-
 
 
 
1 has not been previously described, yet
our experiments suggest that it occurs in NCSCs. We see
up-regulation of MCIP-1 and NFATc1, both of which are
calcineurin target genes, in response to TGF-
 
 
 
1. In addi-
tion, expression of either calcineurin or NFATc1 mimics the
effects of TGF-
 
 
 
1 on NCSCs. This suggests an epistatic re-
lationship between TGF-
 
 
 
1 and the calcineurin pathway in
smooth muscle differentiation, a relationship in which
TGF-
 
 
 
1 activates calcineurin signaling to initiate the differ-
entiation program. The discovery of this potential relation-
ship between the TGF-
 
 
 
1 and calcineurin pathways high-
lights the strengths of the NCSC system as a tool to study
SMC differentiation and demonstrates how NCSCs can be
used to better define relationships between various factors
known to be important for SMC differentiation.
TGF-
 
 
 
1 might activate calcineurin by any one of a variety
of mechanisms. It has been demonstrated that in some cell
types, TGF-
 
 
 
1 is capable of increasing intracellular calcium
to levels adequate for calcineurin activation (Alevizopoulos
et al., 1997). Therefore, direct activation of calcineurin by
TGF-
 
 
 
1 is one plausible mechanism. Activation of cal-
cineurin would lead to dephosphorylation and activation of
NFATs, and then to transcriptional activation of NFAT tar-
get genes, including MCIP-1 and NFATc1. Other possible
mechanisms include direct activation of genes encoding
more downstream components of the calcineurin signaling
pathway, such as NFATc1, by TGF-
 
 
 
1, in a Smad-depen-
dent or -independent manner.
The convincing demonstration that activation of the cal-
cineurin pathway by TGF-
 
 
 
1 is necessary for TGF-
 
 
 
1–
induced smooth muscle differentiation, and a precise defini-
tion of the mechanism by which TGF-
 
 
 
1 activates the
calcineurin signaling pathway, would be of great interest.
Experiments to accomplish these aims are ongoing in our
laboratory.
 
Materials and methods
 
NCSC isolation
 
NCSC isolation has been described in detail previously (Morrison et al.,
1999; Bixby et al., 2002; Kruger et al., 2002; Moon et al., 2002). In brief,
rat E14.5 sciatic nerves or gut (stomach and intestine) were dissected. Dis-
aggregated sciatic nerve cells were stained with antibodies to p75 and P0,
and cells with high p75 and low P0 were isolated by FACS
 
®
 
. Disaggre-
gated gut cells were stained with antibodies to p75 and 
 
 
 
-4, and cells with
Figure 6. NFATc1 transcript levels increase in TGF-treated NCSCs. 
NCSCs were treated with TGF- 1 for 24–48 h, and then total RNA 
was isolated and quantitative real-time PCR was performed using 
NFATc1-specific primers. Both GAPDH and  -actin transcripts were 
also quantitated, and levels of NFATc1 transcript were normalized to 
either GAPDH or  -actin. The result was virtually identical using 
either GAPDH or  -actin to normalize (mean of 4.6, SD of 0.4 or 
mean of 4.5, SD of 0.5, respectively, three independent experiments). 
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high p75 and high 
 
 
 
-4 were isolated by FACS
 
®
 
. NCSCs were cultured at all
times in low oxygen chambers (1% oxygen, 5% CO
 
2
 
). Gut and sciatic
nerve stem cells responded in an identical manner to transduction with
calcineurin, MCIP-1, and GSK-3
 
 
 
.
 
Generation of a subtracted library specific for differentiating 
smooth muscle
 
This generation was described previously (Moon et al., 2002). In brief, sci-
atic nerve stem cells were treated with 20 pM TGF-
 
 
 
1 for 24 h, and then
mRNA was isolated and cDNA made. This cDNA library was subtracted
with cDNA from pluripotent NCSCs that had not been treated with TGF-
 
 
 
1.
 
Virtual Northern blot of MCIP-1
 
Virtual Northern blot of MCIP-1 was described previously (Moon et al.,
2002). Full-length first-strand cDNA from untreated, pluripotent NCSCs or
from NCSCs treated with TGF-
 
 
 
1 for 24 h was amplified for a limited num-
ber of cycles using the Advantage system (CLONTECH Laboratories, Inc.),
which should result in proportional amplification. The cDNA was run out
on an agarose gel, blotted, and hybridized to an MCIP-1–specific probe us-
ing standard procedures. Blots were stripped and reprobed with GAPDH
as an internal control.
 
Cloning of constitutively active calcineurin, NFATc1, GSK-3
 
 
 
, 
and MCIP-1 into the pMIG vector
 
High fidelity PCR was used to obtain cDNAs encoding MCIP-1, a trun-
cated calcineurin coding sequence (1–398 aa), and S9A GSK-3
 
 
 
 from rat
cDNA. The calcineurin and GSK proteins produced by these cDNAs are
constitutively active (O’Keefe et al., 1992; Ohteki et al., 2000). All PCR
products were sequenced to ensure that no PCR-induced mutations had
occurred and were cloned into pMIG using standard techniques. A cDNA
encoding human NFATc1 was subcloned from a construct provided by G.
Crabtree (Stanford University, Stanford, CA).
 
Production of retrovirus and transduction of NCSCs
 
The BOSC packaging cell line (Pear et al., 1993; Pear, 1996) was trans-
fected with pMIG constructs using standard calcium phosphate tech-
niques. 250 ng of the pHCMV-G plasmid (a gift from N. Hopkins, Mas-
sachusetts Institute of Technology, Cambridge, MA), which encodes
vesicular stomatitis virus glycoprotein, was cotransfected with each pMIG
construct. Media were changed the next day, and 18 h later the media
were taken off and used as vesicular stomatitis virus glycoprotein–pseudo-
typed viral stock (Hopkins, 1993). NCSCs were transduced by removing
half the medium in each well and replacing it with viral stock. Polybrene
was also added, to a final concentration of 1 
 
 
 
g/ml. Cells were incubated
for 4 h, whereupon the media were replaced.
 
Flow cytometry of transduced NCSCs
 
NCSCs that had been transduced with retrovirus were fixed with the Cyto-
fix/Cytoperm kit (BD Biosciences). After fixation, cells were stained with
an antibody to SMA (anti-SMA; A2547; Sigma-Aldrich) and a phycoeryth-
rin (PE)-conjugated secondary antibody (115-116-146; Jackson Immu-
noResearch Laboratories). 10,000 cells from each sample were assessed
for GFP and PE fluorescence by a FACScan flow cytometer (Becton Dickin-
son). Mock-transduced cells were used as a GFP-negative control, and
cells stained with nonspecific isotype-matched IgG (554126; BD Bio-
sciences) in place of anti-SMA were used as an actin-negative control.
 
Clonal analysis
 
300–400 NCSCs were sorted to each well of a 12-well plate, and were
transduced on the following day. The day after transduction, the cells were
removed with trypsin and immediately replated. Each well of a 12-well
plate was replated to 6 wells of a 6-well plate. The cells were grown for
6–10 d, whereupon they were inspected by fluorescence microscopy and
GFP-positive colonies were identified. In most experiments, all or very
nearly all colonies were GFP positive, indicating that they had been ef-
fectively transduced. After confirming successful transduction, the plates
were stained with anti-SMA, anti-glial fibrillary acidic protein (anti-GFAP;
G3893; Sigma-Aldrich), a PE-conjugated antibody reactive with anti-GFAP
(Southern Biotechnology Associates 1070–09), a FITC-conjugated anti-
body reactive against anti-SMA (1080-02; Southern Biotechnology Associ-
ates, Inc.), and DAPI. Colonies were visualized on an epifluorescence mi-
croscope (model Diaphot 300; Nikon) and photographed with a 35-mm
camera (model FX-35DX; Nikon), using NPZ 800 ISO film (Fuji), with the
camera set at 1600 ISO. Photographs were scanned into Photoshop using a
scanner (model Expression 1680; Epson).
 
Immunostaining of transduced colonies
 
Cells were fixed with acid/ethanol (Kruger et al., 2002) and stained with
anti-SMA, anti-GFAP, and DAPI as described in the preceding section. In
the experiment shown in Fig. 4 C, cells were stained with antibody against
smooth muscle myosin heavy chain (M7786; Sigma-Aldrich) or anticalpo-
nin (C2687; Sigma-Aldrich). The same secondary antibody (1070-09;
Southern Biotechnology Associates, Inc.) was used for both of these pri-
mary antibodies. Colonies were examined, characterized, and photo-
graphed under a fluorescence microscope as described for the clonal anal-
ysis experiments.
 
Quantitative real-time PCR
 
PCR primers that amplified a fragment of 80–160 bp were designed and
were shown to target a unique sequence by using BLAST searches of the
rat genome. 500–1,500 NCSCs (from gut or sciatic nerve) were sorted to
each well of a 12-well plate and grown for 5–6 d, at which time TGF-
 
 
 
1
was added to a final concentration of 20 pM. 24–48 h later, total RNA was
isolated using the RNAqueous-Micro kit (Ambion). First-strand cDNA was
made from total RNA by random priming using the SuperScript First Strand
Synthesis System (GIBCO BRL), yielding a final volume of 20 
 
 
 
l cDNA.
Quantitative real-time PCR reactions were performed on a LightCycler
(Roche), using FastStart DNA Master SYBR Green I reagents (Roche). A 1-
 
 
 
l
volume of cDNA (either undiluted or diluted 1:5 with water) was used in
each quantitative real-time PCR reaction. Cycle number for each reaction
was determined by taking the crossing point of a tangent to the log-linear
portion of the curve of cycle number versus fluorescence. Relative
amounts of cDNA (target compared with internal control) were determined
using an estimated efficiency of 1.8-fold amplification per cycle. Melting
curve analysis was performed for each reaction to rule out primer dimer
formation and to ensure that a unique product was generated.
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